China Gout Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
China · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$266.4 MnPlaceholder estimate
Estimate 2025$292.5 Mn7.2% of the global market
Projected 2034$678.4 Mn 132%Adds $386.0 Mn over 9 forecast years
CAGR 2025–20349.8%Faster than 54% of 180 Pharmaceuticals markets here
Key players5
China is 7.16% of the global market.
In APAC, the largest is China (this report) at $292.5 Mn.
13 in ChinaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The China Gout Treatment Market Analysis Executive Summary
Gout treatments lower uric acid and control painful flares caused by crystals in the joints.
Key segments of the gout Treatment market include drug class (Xanthine Oxidase Inhibitors, Uricosurics and Colchicine) and type (Acute Gout and Chronic Gout).
China Gout Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
China Gout Treatment Market Dynamics
Market Growth Drivers
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the gout Treatment market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.
Opportunity
Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the gout Treatment market, especially in fast-growing emerging economies.
Market Restraints
High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the gout Treatment market. Long-term safety data and lifestyle support are still needed for many patients.
Competitive Landscape for Gout Treatment Market in China
The gout Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Gout Treatment Market in China
Gout Treatment in China: rules, payment and research
Drugs need approval from the National Medical Products Administration (NMPA) before sale.[1] Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List.[2] ClinicalTrials.gov lists 13 studies on Gout Treatment that are recruiting, active or about to start in China.[3]
[3]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.
Policy changes and Reimbursement scenario
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for gout Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in China.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Drug Class
4.2 By Type
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Horizon Therapeutics (Amgen)
7.2 Takeda
7.3 Novartis
7.4 Teva Pharmaceutical
7.5 Shanton Pharma
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The gout Treatment market can be segmented based on various criteria, including drug class, type and end user. Here's a breakdown of the market segmentation
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Gout Treatment right now, from free public sources.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Gout Treatment in context
China compared
Health spending per person: 763 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 15 countries we cover in APAC.[1]
Doctors: 3.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 15 countries we cover in APAC.[2]
People aged 65 and over: 14.9% of people (2025). World: 10.4% of people (2025). 6th highest of the 16 countries we cover in APAC.[3]
[1]World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.
Placeholder estimate: about $292.5 Mn in 2025, rising to about $678.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Gout Treatment market in China growing?
Placeholder estimate: about 9.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Gout Treatment market report cover?
The report splits the market by drug class (Xanthine Oxidase Inhibitors, Uricosurics, Colchicine, NSAIDs and more), type (Acute Gout, Chronic Gout) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Gout Treatment market?
Key players include Horizon Therapeutics (Amgen), Takeda Pharmaceutical Company Ltd, Novartis AG, Teva Pharmaceutical and Shanton Pharma.
What is driving the Gout Treatment market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the gout Treatment market.
Who regulates Gout Treatment in China?
Drugs need approval from the National Medical Products Administration (NMPA) before sale. Source: National Medical Products Administration. Checked 14 Nov 2026.
How is healthcare paid for in China?
Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List. Source: National Healthcare Security Administration. Checked 14 Nov 2026.
How many clinical trials on Gout Treatment are running in China?
13 studies are recruiting, active or about to start in China, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.
How much research is published on Gout Treatment?
PubMed lists 135 papers on Gout Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
China 
India
US
Canada
Japan
Germany
France
UK
Brazil
Italy
Ecuador
Spain
Saudi Arabia
Mexico
Australia
Russia
New Zealand
South Africa
UAE
Egypt
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
Aurobindo Pharma
Dr Reddy’s Laboratories
Hikma Pharmaceuticals PLC
Glenmark Pharmaceuticals